CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Colorado and Washington were the first states to legalize recreational cannabis use in 2012.

Treatment 105

Treatment Legalization Marijuana Research and Development 105

Illinois News Joint

JANUARY 9, 2025

Data suggests that cannabis can be helpful for women with difficulties or dysfunction attaining orgasm. Providers are now able to begin certifying patients with those conditions for treatment with medical cannabis. The post IDPH approves four new conditions for medical cannabis treatment appeared first on Illinois News Joint.

Conditions 105

Conditions Treatment Chronic Pain Epilepsy 105

Veriheal

AUGUST 15, 2022

In their recently published study, titled “The Effects of Consuming Cannabis Flower for Treatment of Fatigue,” the UNM researchers proved that the Cannabis sativa plant instantly reduced feelings of fatigue in most consumers. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application.

Treatment 102

Treatment Research and Development Sativa Cannabinoids 102

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 114

Data Research and Development Patients Strains 114

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. ” In observational models , patients with legal access to cannabis typically reduce or eliminate their use of opioids.

Clinical Trials 197

Clinical Trials CBD History Data 197

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

DECEMBER 27, 2019

The main goals with conducting clinical studies, which could include observational studies or clinical trials, are to explore the causes of a disease or its symptoms, test a treatment, and learn how a certain behaviour affects patients’ health. AI-Powered search platform maximizes access to publications.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

Cannabis Chronicles

MAY 22, 2019

The partnership between the land grant institution in Pullman and the Tacoma-based native tribe is intended to create a standard to evaluate treatment plans at a natural healing clinic the Puyallups opened in October, and to determine the effectiveness of the drug as an alternative to opioids in managing pain.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.

Data 105

Data Access Medicine Patients 105

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

LifeCannMD

APRIL 28, 2025

For an engineer like Rick, who understood the value of evidence and data, it was a revelation. The conventional treatments weren’t appealing, and here was something he could make himself, based on actual research. Instead, he wanted everyone to have access to it. Something clicked in Rick’s mind.

History 82

History Chronic Pain Research and Development Oil 82

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

CannaMD

MARCH 4, 2020

The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. The goal of the CannaMD /Releaf partnership is to collect and leverage data-backed insights to improve the quality of healthcare for registered medical cannabis patients in Florida.

Patients 98

Patients Data Collective Treatment 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

CannaMD

MARCH 3, 2021

A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. This data suggests a buffering effect of legalization on crime in neighboring areas, rather than a crime-inducing effect.

Legalization 119

Legalization Marijuana Data Safety 119

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

NORML

APRIL 4, 2019

Our outdated laws have ruined lives, devastated communities, and wasted resources for critical medical treatment and research. Sixty-eight percent of registered voters “support the legalization of marijuana,” according to 2018 national polling data compiled by the Center for American Progress. ” Said Rep.

Policy 179

Policy Business Marijuana Research and Development 179

SpeedWeed

MARCH 31, 2021

The CDC report found “a precipitous national decline in adolescent treatment admissions, particularly in states legalizing recreational marijuana use,” states study author Jeremy Mennis, Ph.D. “7 CDC data aligns with most surveys. CDC data aligns with most surveys. The data on this issue is clear, consistent, and available.

Treatment 52

Treatment Data Vaping Recreational 52

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Patients can also access CBD products without a prescription through local pharmacies. Parkinson’s disease and cannabis.

Patients 97

Patients Clinical Trials Research and Development Treatment 97

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. The deadline for proposals is Friday, July 16. Between Dec. 1, 2019, the day legal sales began, and Sept.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JANUARY 6, 2022

Mental health treatment is big business, with the global antidepressant drug market valued at over $13 billion in 2016. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon. The Race to Patent Psilocybin.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Forward-Looking Statements.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Medical cannabis is a safer alternative to the conventional opiate solutions and other pain management treatments. About LYPHE GROUP.

Extraction 105

Extraction Vaping Medicine Patients 105

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7% in those who had completed treatment, and as high as 66.7%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. All imaging and behavioral data will be accessible to the public after the study is complete. Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

DECEMBER 26, 2021

21, 2021 /PRNewswire/ — Ixtlan Bioscience , a biotech company focused on developing psilocybin-based treatment for Alzheimer’s Disease and Brain Pathologies, has announced today the filing of a new Provisional Patent with the United States Patent and Trademark Office (USPTO) Application No. TEL AVIV, Israel , Dec.

Treatment 52

Treatment Patients Data Access 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 111

Consumption Patients Research and Development Data 111

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

MAY 26, 2022

RoC also works to increase patients’ access to medical cannabis by helping U.S. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98